GlassScriptPhysician profile
Christopher Anthony Cefalu
NPI 1861717662
$1,495.43
in general payments reported to CMS, 2019-2025
21 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $22.04 · 2021: $151 · 2022: $393 · 2023: $131 · 2024: $160 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $269.41 | 2019-2025 | Greenlight Xps, General - Kidney Stone Disease |
| Axonics, INC. | $176.49 | 2022-2024 | Axonics |
| Astellas Pharma US INC | $165.59 | 2019-2021 | |
| Urogen Pharma, INC. | $155.50 | 2022 | |
| Janssen Biotech, INC. | $123.48 | 2019 | |
| Abbvie INC. | $110.24 | 2019 | |
| Pfizer INC. | $72.40 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $51.00 | 2022 | |
| Olympus America INC. | $50.74 | 2024-2025 | Itind System |
| Dendreon Pharmaceuticals LLC | $38.94 | 2019 | |
| Integra Lifesciences Corporation | $38.52 | 2024-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Bayer Healthcare Pharmaceuticals INC. | $37.16 | 2019 | |
| Coloplast Corp | $29.39 | 2025 | |
| Myovant Sciences INC. | $27.93 | 2022 | |
| Steris Corporation | $27.16 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $26.67 | 2025 | Echelon; Endopath |
| Merck Sharp & Dohme LLC | $25.05 | 2025 | Keytruda |
| Siemens Medical Solutions USA, INC. | $21.65 | 2023 | Cios Flow |
| Amgen INC. | $17.16 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.67 | 2024 | Xarelto |
| Metuchen Pharmaceuticals | $14.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cefalu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.